Literature DB >> 33630044

What Is Just the Right Amount of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema?: Protocol V and the Goldilocks Principle.

Michael A Grassi1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33630044     DOI: 10.1001/jamaophthalmol.2021.0013

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  2 in total

1.  Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept.

Authors:  Donald R Nixon; Nicholas Flinn; Claudia Enderlein
Journal:  Clin Ophthalmol       Date:  2021-11-11

2.  Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context.

Authors:  Diana V Do; Hadi Moini; Charles C Wykoff
Journal:  BMJ Open Ophthalmol       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.